Head and Neck Cancer Clinical Research

Active Research Studies for Head and Neck Cancers

Comprehensive Cancer Centers runs research studies for the following head and neck cancers:

A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants with Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Study#: PENDING
Contact Us: For information about this clinical study, Email Us.